Back
Neurocrine Biosciences Stock Predictions
Why Private Investors Didn't Lose a Penny in the Market's Recent $1T Crash
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
40
NBIX
Neurocrine Biosciences
Last Price:
$113.24
Seasonality Move:
6.8%
7 Day Trial
ALL ACCESS PASS
$
7
Meet the founder that's revolutionizing smartphones
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.Neurocrine Biosciences Stock Forecast
-
Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 35.1% based on the past 28 years of stock performance.
-
Neurocrine Biosciences has risen higher in 17 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.71%
-
Is Neurocrine Biosciences Stock Undervalued?The current Neurocrine Biosciences [NBIX] share price is $113.16. The Score for NBIX is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
-
NBIX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Neurocrine Biosciences Stock Go Up Next Year?
-
Over the next 52 weeks, Neurocrine Biosciences has on average historically risen by 35.1% based on the past 28 years of stock performance.
Neurocrine Biosciences Stock Rating
Sell
40
Neurocrine Biosciences (NBIX)
is a Sell
Is Neurocrine Biosciences overpriced?
-
Neurocrine Biosciences has risen higher in 17 of those 28 years over the subsequent 52-week period, corresponding to a historical accuracy of 60.71%
Neurocrine Biosciences Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
neurocrine.com
52-Week Data
52-Week High:
157.98
52-Week Low:
105.18
Prediction Charts
Market Cap:
11.3B
Price in USD:
113.16
Volume:
800.8K
Beta:
0.77
Technical Analysis
SMA50:
125.75
SMA100:
127.58
SMA200:
129.92
52-Wk Change:
-17.95%
Stock Predictions
-
Is Neurocrine Biosciences stock public?Yes, Neurocrine Biosciences is a publicly traded company.
-
What is the Neurocrine Biosciences stock quote today?The Neurocrine Biosciences stock price is 113.16 USD today.
-
How to buy Neurocrine Biosciences stock online?You can buy Neurocrine Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Mar-11 | 109.12 | 107.22 | 110.07 | 105.18 |
| Mar-12 | 108.45 | 109.07 | 109.56 | 106.83 |
| Mar-13 | 108.84 | 108.99 | 110.21 | 108.18 |
| Mar-14 | 109.00 | 110.75 | 111.27 | 108.03 |
| Mar-17 | 110.29 | 111.50 | 112.74 | 109.68 |
| Mar-18 | 111.12 | 109.70 | 111.12 | 109.43 |
| Mar-19 | 109.70 | 110.31 | 110.69 | 109.47 |
| Mar-20 | 109.86 | 110.07 | 111.25 | 109.83 |
| Mar-21 | 109.39 | 111.92 | 112.53 | 109.34 |
| Mar-24 | 112.65 | 115.60 | 115.76 | 112.59 |
| Mar-25 | 115.33 | 116.18 | 116.23 | 114.45 |
| Mar-26 | 116.23 | 114.45 | 116.23 | 113.05 |
| Mar-27 | 114.47 | 114.00 | 115.80 | 113.55 |
| Mar-28 | 113.36 | 113.16 | 114.43 | 112.15 |
Neurocrine Biosciences Earnings
Neurocrine Biosciences Earnings Report: Per Share Neurocrine Biosciences Earnings Q1 Q2 Q3 and Q4 last year and next year.
Neurocrine Biosciences Forecast Revenue Growth
Neurocrine Biosciences Stock Analysis: Historical quarterly revenues per share for Neurocrine Biosciences and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.14 per share, an increase next quarter of $0.54 per share, a decrease this year of $0.28 per share, and an increase next year of $2.62 per share.
* Neurocrine Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.